Sort   by:  
 Page size 
UnknownA phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.
Not available
S-EPMC10189379 | biostudies-literature
UnknownIbrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial.
Not available
S-EPMC8193546 | biostudies-literature
UnknownIbrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations.
Not available
S-EPMC11812922 | biostudies-literature
UnknownIbrutinib and Venetoclax for First-Line Treatment of CLL.
Not available
S-EPMC11827445 | biostudies-literature
UnknownGlobal anaesthesia practice using inguinal hernia surgery as a tracer condition: a secondary analysis of an international prospective cohort study.
Not available
S-EPMC12519944 | biostudies-literature
UnknownInternational Impact of COVID-19 on the Diagnosis of Heart Disease.
Not available
S-EPMC7836433 | biostudies-literature
UnknownImpact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World.
Not available
S-EPMC8374310 | biostudies-literature
UnknownCause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.
Not available
S-EPMC4943233 | biostudies-literature
UnknownImpact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study.
Not available
S-EPMC9627847 | biostudies-literature
Sort   by:  
 Page size